WORCESTER, Mass.--(BUSINESS WIRE)--RXi Pharmaceuticals Corporation (Nasdaq: RXII), a biopharmaceutical company pursuing the development and commercialization of proprietary therapeutics based on RNA interference (RNAi), today reported that Victor Ambros, Ph.D., a member of RXi’s Scientific Advisory Board (SAB), has been awarded the 2008 Albert Lasker Award for Basic Medical Research.
